MPD Holdings, backed by Addison Capital Partners and Global Healthcare Partners, has named Carrington Smith as chief executive officer. He has also joined the board of directors. Smith spent more than 20 years at Air Products and Chemicals in various positions. Addison Capital, along with Global Healthcare Partners, completed a recapitalization of MPD Holdings in 2012.
MPD Holdings, LLC, d/b/a MPD Chemicals (“MPD”), is pleased to announce the appointment of Carrington D. Smith, Ph.D. as Chief Executive Officer, effective February 1, 2014. Dr. Smith is also elected a member of the Board of Managers.
“We welcome Carrington’s experience and leadership to MPD,” said Brian Miller, MPD Executive Chairman and Principal of Addison Capital Partners. “The Board is excited about the possibilities and is confident that under Carrington’s leadership, MPD will further its growth objectives and realization of the greater enterprise.” Board member and investor, Lodewijk de Vink added “Carrington’s results-oriented approach and ability to think strategically will play a pivotal role in extending MPD’s track record of innovation, while providing leadership and business development initiative to each operating unit.”
“I am quite pleased to join MPD and am eager to leverage the diverse capabilities of each business unit and to fully capitalize on new business opportunities, building on the demonstrated successes with our existing customers,” said Dr. Smith.
Dr. Smith brings considerable and relevant industry experience to MPD having previously spent over 20 years at Air Products and Chemicals, Inc. in various positions throughout the organization. Dr. Smith has a demonstrated track record of leadership with visionary qualities and broad technology, business development and M&A- related expertise. Carrington earned a BS in Chemistry from Virginia Commonwealth University and a Ph.D. in Chemistry with a focus on polymer science from Virginia Tech.
About MPD Chemicals
MPD Chemicals is a US-based manufacturer of specialty chemicals with expertise in multiple technical areas including complex organic synthesis, unique monomers, polymer development, organosilicon chemistries and stable isotope labeling. The individual business units that comprise MPD are Monomer-Polymer and Dajac Labs, Silar and IsoSciences. The recent combination of these entities into a single organization allows for further development of novel materials and solutions for client application needs by leveraging the Company’s cross-disciplinary expertise and operational strength when internally scaling from milligram to metric ton batches. For more information please go to www.mpdchemicals.com.
About Addison Capital
Addison Capital is a private equity investment firm that seeks out partnerships with owners and operators of lower middle market growth companies to provide liquidity, growth capital and management resources to grow and build exceptional enterprises.
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE MPD Chemicals